Allogene Therapeutics Inc (ALLO)

Total Costs & Expenses

$51.56M

Quarterly · Period ending: · USD

ALLO logo

ALLO Total Costs & Expenses

Latest reported$51.56M
ALLO Quarterly Total Costs & Expenses ($2.00K → $51.56M)
High-resolution chart · PNG

ALLO total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Allogene Therapeutics Inc Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
51,560,000
46,092,000
42,404,000
44,901,000
56,819,000
65,191,000
60,490,000
71,774,000
71,431,000
69,526,000
85,130,000
63,018,000
80,562,000
99,122,000
96,421,000
82,538,000
76,680,000
80,053,000
73,944,000
77,719,000
71,073,000
71,546,000
69,362,000
68,040,000
63,158,000
57,683,000
64,575,000
55,011,000
45,961,000
36,461,000
33,046,000
22,187,000
135,012,000
2,597,000
2,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.